Abstract: The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.

Abstract: A method for distributed application distribution may include: (1) receiving, at a first decentralized marketplace instance in a distributed ledger network and from a first node of the plurality of nodes, the first node associated with a distributed application creator, a distributed application; (2) making available, by the first decentralized marketplace instance, the distributed application to decentralized marketplace instances, wherein the first node is configured to provide the distributed application to a second node, the second node associated with a distributed application collaborator; (3) receiving, at a second decentralized marketplace instance and from the second node, a modified version of the distributed application; and (4) making available, by the second decentralized marketplace instance, the modified version of the distributed application to the decentralized marketplace instances, wherein the second node is configured to provide the distributed application to a third node, the third node a

Abstract: In some implementations, a first network device may receive, from a second network device associated with a first core network, a communication associated with a low power wide area (LPWA) technology. The first network device may convert the communication associated with the LPWA technology from a first protocol associated with the first core network to a second protocol associated with a second core network different from the first core network. The first network device may transmit, to a third network device associated with the second core network, the communication associated with the LPWA technology.

Abstract: An apparatus includes a first stapling assembly, a plurality of staples a plurality of staple drivers, and a second spelling assembly portion. The first stapling assembly portion has a deck surface defining a plurality of apertures. The staple drivers can drive the plurality of staples through the staple apertures of the deck surface. The second stapling assembly can couple with the first stapling assembly portion. The second stapling assembly portion has a section that overlies the deck surface. At least one of the first or second stapling assembly portions include a first support feature that inhibits deflection of the deck surface during stapling.

Abstract: An apparatus includes a staple, a body, a staple driver, and an alignment feature. The alignment feature is coupled to or formed with at least one of the staple driver or an inner surface of the staple aperture of the body. The alignment feature is configured to minimize rotation of the staple driver. The alignment feature includes at least one of a first contact feature, an alignment member, an alignment member, or an inwardly tapering portion. The first contact feature projects beyond a first lateral side of the staple driver. The alignment member extends through at least a portion of the staple driver. The first connecting portion rigidly connects the inner surface of the staple aperture with the staple driver in a connected state. The inwardly tapering portion of the inner surface or the staple driver is configured to guide the staple driver.

Abstract: An Internet of Things (IoT) device may receive a network configuration profile including one or more parameters relating to a scan interval and a mode priority of the IoT device indicating a priority for a first IoT network over a second IoT network. The IoT device may scan for an availability of the first IoT network. Based on determining that the first IoT network is unavailable, the IoT device may scan for an availability of the second IoT network. Based on determining that the second IoT network is available, the IoT device may initiate a network connection with the second IoT network. While connected to the second IoT network, the IoT device may scan for the availability of the first IoT network. Based on determining that the first IoT network is available, the IoT device may initiate a network connection with the first IoT network.

Abstract: An IoT device may maintain a list of cells that fail to support features of the IoT device and may scan a designated frequency band to identify strongest cells in the designated frequency band. The IoT device may decode one or more signals from one or more of the identified strongest cells that are not included in the list and may determine, based on the decoded one or more signals, a first subset of the one or more of the identified strongest cells that support features of the IoT device and a second subset of the one or more of the identified strongest cells that fail to support features of the IoT device. The IoT device may select a particular cell of the first subset of the one or more of the identified strongest cells that support features of the IoT device and may attach to the particular cell.

Abstract: A user device may be provisioned with a list of paths for connecting to a network. A method may include determining that the user device has attached to a visited network and sending the visited network an indication of connectivity capabilities associated with the network. The method may include receiving an indication of one or more paths established from the visited network to the network based on capabilities of the visited network. The one or more paths may be included in the list of paths. The method may include transmitting data to or from the user device via a first path of the one or more paths.

Abstract: The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.

Abstract: A method, a device, and a non-transitory storage medium are described in which an admission and congestion control service is provided. The service may dynamically reconfigure admission control information of an end device. The admission control information may include one or multiple types of access class values of the end device or an application of the end device.

Abstract: A device may determine that an application server requires an IPv6 address of a user equipment, and may provide, to another network device, a request for the IPv6 address of the user equipment, wherein the request includes data identifying an IP address of the network device and a port of the network device, and wherein the request is to cause the other network device to provide the request for the IPv6 address to the user equipment via a SMS request message, and receive, from the user equipment, data identifying the IPv6 address and a port of the user equipment via a SMS response message. The network device may receive, from the other network device, a response that includes the data identifying the IPv6 address and the port of the user equipment, and may store the data identifying the IPv6 address and the port of the user equipment.

Abstract: A device may send a first message to a user device requesting information identifying a radio access technology (RAT) or a band supported by and enabled on the user device. The device may receive an indication of the RAT or band supported by and enabled on the user device and send, to the user device, a second message instructing the user device to modify the RAT or band enabled on the user device. The second message may include an indication of updated RAT or band information. The device may receive from the user device, a confirmation that the RAT or band enabled on the user device has been modified.

Abstract: The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.

Abstract: A device may determine that an application server requires an IPv6 address of a user equipment, and may provide, to another network device, a request for the IPv6 address of the user equipment, wherein the request includes data identifying an IP address of the network device and a port of the network device, and wherein the request is to cause the other network device to provide the request for the IPv6 address to the user equipment via a SMS request message, and receive, from the user equipment, data identifying the IPv6 address and a port of the user equipment via a SMS response message. The network device may receive, from the other network device, a response that includes the data identifying the IPv6 address and the port of the user equipment, and may store the data identifying the IPv6 address and the port of the user equipment.

Abstract: A base station may cause a user equipment (UE) to be connected to a network, wherein an attach request message, that is used to connect the UE to the network, includes one or more eligibility parameters for a connection release service. The base station may determine, based on the one or more eligibility parameters, that the UE is to receive the connection release service. The base station may provide, to the UE, a connection release message that is provided based on determining that the UE is to receive the connection release service. The base station may receive, from the UE, a connection release acknowledgement message that indicates that the connection release message has been received by the UE. The base station may perform one or more actions associated with changing a state of the UE based on receiving the connection release acknowledgement message.

Abstract: A user device may be provisioned with a list of paths for connecting to a network. A method may include determining that the user device has attached to a visited network and sending the visited network an indication of connectivity capabilities associated with the network. The method may include receiving an indication of one or more paths established from the visited network to the network based on capabilities of the visited network. The one or more paths may be included in the list of paths. The method may include transmitting data to or from the user device via a first path of the one or more paths.

Abstract: A device may send a first message to a user device requesting information identifying a radio access technology (RAT) or a band supported by and enabled on the user device. The device may receive an indication of the RAT or band supported by and enabled on the user device and send, to the user device, a second message instructing the user device to modify the RAT or band enabled on the user device. The second message may include an indication of updated RAT or band information. The device may receive from the user device, a confirmation that the RAT or band enabled on the user device has been modified.

Abstract: A method for manipulating tissue of a patient includes a surgical instrument having a handle assembly, a shaft assembly, and an end effector. The method includes positioning a tissue within a gap between a cartridge and an anvil and against a guide pin to laterally position the tissue relative to the cartridge and the anvil. The method also includes moving a retaining pin from an open position to a closed position to capture the tissue and moving the cartridge toward the anvil in a closed configuration. Furthermore, the method includes inhibiting deflection of a distal end portion of the end effector wherein at least at least one of the guide pin or the retaining pin connects to the distal end portion. The method further includes forming a plurality of staples within the tissue and cutting the tissue with a knife.

Abstract: An Internet of Things (IoT) device may receive a network configuration profile including one or more parameters relating to a scan interval and a mode priority of the IoT device indicating a priority for a first IoT network over a second IoT network. The IoT device may scan for an availability of the first IoT network. Based on determining that the first IoT network is unavailable, the IoT device may scan for an availability of the second IoT network. Based on determining that the second IoT network is available, the IoT device may initiate a network connection with the second IoT network. While connected to the second IoT network, the IoT device may scan for the availability of the first IoT network. Based on determining that the first IoT network is available, the IoT device may initiate a network connection with the first IoT network.

Abstract: A base station may cause a user equipment (UE) to be connected to a network, wherein an attach request message, that is used to connect the UE to the network, includes one or more eligibility parameters for a connection release service. The base station may determine, based on the one or more eligibility parameters, that the UE is to receive the connection release service. The base station may provide, to the UE, a connection release message that is provided based on determining that the UE is to receive the connection release service. The base station may receive, from the UE, a connection release acknowledgement message that indicates that the connection release message has been received by the UE. The base station may perform one or more actions associated with changing a state of the UE based on receiving the connection release acknowledgement message.